These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38734769)

  • 1. Rx -to- OTC switch increased access and lowered cost of topical adapalene.
    Fix W; Desai S; Nussbaum D; Friedman A
    Arch Dermatol Res; 2024 May; 316(5):155. PubMed ID: 38734769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In brief: An over-the-counter retinoid for acne.
    Med Lett Drugs Ther; 2016 Sep; 58(1504):126. PubMed ID: 27649343
    [No Abstract]   [Full Text] [Related]  

  • 3. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of female acne on patterns of health care resource utilization.
    Baldwin HE; Kawata AK; Daniels SR; Wilcox TK; Burk CT; Tanghetti EA
    J Drugs Dermatol; 2015 Feb; 14(2):140-8. PubMed ID: 25689809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
    Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA
    Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapalene: a review of its use in the treatment of acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Drugs; 2004; 64(13):1465-78. PubMed ID: 15212561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe Use of Adapalene 0.1 % Gel in a non-Prescription Environment.
    Weiss J; Mallavalli S; Meckfessel M; Griffin S; Wagner N
    J Drugs Dermatol; 2021 Dec; 20(12):1330-1335. PubMed ID: 34898146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pneumatic broadband light plus adapalene gel 0.3% versus adapalene gel 0.3% monotherapy in the treatment of mild to moderate acne.
    Tangjaturonrusamee C; Rattanaumpawan P; Ditre CM
    Cutis; 2016 Jul; 98(1):56-61. PubMed ID: 27529709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.
    Carlsten A; Wennberg M; Bergendal L
    J Clin Pharm Ther; 1996 Dec; 21(6):423-30. PubMed ID: 9201570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
    Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
    J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.
    Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Arsonnaud S; Kang S;
    Skinmed; 2005; 4(3):138-46. PubMed ID: 15891249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapalene in the treatment of African patients.
    Jacyk WK
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():37-42. PubMed ID: 11843232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development.
    Cohen J; Millier A; Karray S; Toumi M
    J Med Econ; 2013; 16(6):835-44. PubMed ID: 23597040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on adapalene in acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne.
    Emmerich VK; Purvis CG; Feldman SR
    Expert Opin Pharmacother; 2021 Sep; 22(13):1661-1667. PubMed ID: 34086519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
    Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over the Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice.
    Andriessen A; Rodas Diaz AC; Gameros PC; Macias O; Neves JR; Gonzalez CG
    J Drugs Dermatol; 2021 Mar; 20(3):244-250. PubMed ID: 33683089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.